Study Design Parameters Affecting Exposure Response Analysis of QT Data: Results From Simulation Studies.

Area of Science:

• Pharmacology
• Clinical Pharmacology
• Drug Development

Background:

• The predictive accuracy of dose-escalating studies for drug-induced QT effects is not well-established.
• Understanding the operating characteristics of single-ascending-dose (SAD) studies is crucial for drug safety assessment.

Purpose of the Study:

• To quantitatively evaluate the false-negative prediction rate of QT effects in SAD studies.
• To determine the power of SAD studies to exclude clinically relevant QT effects.

Main Methods:

• Simulated 1000 SAD studies across 32 scenarios, varying QT effects and plasma concentrations.
• Incorporated circadian QT variability and added drug effects to simulated subject data.
• Assessed false-negative rates and power to exclude effects at different QT effect magnitudes and concentration levels.

Main Results:

• False-negative rates were 4%-9% for a 10-millisecond QT effect.
• At therapeutic concentrations with a 6.7-millisecond effect, false-negative rates ranged from 40%-60% with controlled variability.
• Power to exclude a 10-millisecond effect was >70% with controlled variability and supratherapeutic concentrations, but reduced to 36%-69% otherwise.

Conclusions:

• Placebo-controlled SAD studies demonstrate acceptably low false-negative rates for QT effects.
• SAD studies possess significant power to exclude relevant QT effects under specific conditions: minimal drug effect, supratherapeutic concentrations, and controlled QT variability.